Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-018327

Dianthus Therapeutics, Inc. /DE/ · DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Alphabet Inc.
10% Owner
GV 2016, L.P.
10% Owner
Period of report
Jun 25, 2018
Accepted (ET)
Jun 27, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001690585

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 25, 2018C3,339,137—A3,339,137IBy GV 2016, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF1,F2—Jun 25, 2018C133,400D——Common Stock51,6260I
Series B Preferred StockF1,F2—Jun 25, 2018C8,494,864D——Common Stock3,287,5110I

Explanation of responses